Open original FDA record ↗Recall record
- FDA identifier
- Z-0996-2026
- Company in FDA record
- Medtronic Neuromodulation
- FDA classification date
- Dec 23, 2025
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Software issue where a Device Reset message displayed on the app was unable to be cleared. In rare cases, this resulted in an inability to resume therapy, and the patient experienced a recurrence of underlying pain symptoms. Resolution would require surgical replacement of the INS.
Source facts
- Action
- On November 20, 2025, the firm notified customers via Urgent Medical Device Safety Notification letters. Medtronic has developed a new version of the A71100 CP App, v1.0.4489 or later, that contains a fix for this issue by ensuring the ability to clear a Device Reset message by pressing OK if the message appears. Customers should download v1.0.4489 or any later version at your earliest convenience.
- Initiated
- 2025-11-20
- Root cause
- Software design
- Distribution
- Worldwide distribution - US Nationwide and the countries of Argentina, Aruba, Australia, Austria, Belgium, Bosnia And Herzegovina, Brazil, Canada, Canary Islands, Chile, China, Colombia, Costa Rica, Croatia, Cyprus, Czech Republic, Denmark, Ecuador, Egypt, El Salvador, Finland, France, French Polynesia, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, Indonesia, Ireland, Israel, Italy, Japan, Kuwait, Luxembourg, Malaysia, Malta, Mauritius, Mexico, Namibia, Netherlands, New Zealand, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Reunion, Russia, Singapore, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, United Arab Emirates, United Kingdom, Uruguay.
- Recall number
- Z-0996-2026
- Recall status
- Open, Classified
- CDRH record ID
- 217454
- FDA classified
- 2025-12-23
- Recall event number
- 98028